Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2021

01-12-2021 | Diabetic Neuropathy | Research article

Neuroprotective effect of Bauhinia variegata Linn. leaf extracts in streptozotocin induced diabetes in Sprague Dawley rats

Authors: Ankit P. Laddha, Mayuresh S. Garud, Yogesh A. Kulkarni

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2021

Login to get access

Abstract

Background

Bauhinia variegata, a ayurvedic medicinal plant reported for its valuable effects in various diseases. It has shown significant effects in type 1 and type 2 diabetes.

Objective

The present work was designed to study effects of aqueous and alcoholic extract (AE and AlcE) of Bauhinia variegata Linn. leaves in diabetic neuropathy.

Methods

Male Sprague Dawley rats become diabetic using intraperitoneal injection of streptozotocin (STZ) at 55 mg/kg dose. After 6 weeks, animals were divided and were treated with AE and AlcE at a dose of 250, 500, and 1000 mg/kg (p. o.) for the next four weeks. Various parameters such as glucose, thermal hyperagesia, mechanical allodynia, MNCV and oxidative stess were assessed at the end of the study.

Results

Diabetic animals showed a significant reduction in response time in tail immersion and hot plate test as compared to animals in normal control group. AE and AlcE at 250, 500, and 1000 mg/kg dose significantly increased response time in the tail immersion test. Whereas, AE and AlcE at doses 500 and 1000 mg/kg showed significant improvement and in response time in the hot plate test.
AlcE at 250, 500 and 1000 mg/kg dose increased the nociceptive threshold significantly. AE at doses 500 and 1000 mg/kg showed significant improvement in the nociceptive threshold. The decrease in motor nerve conduction velocity was observed in diabetic control animals, which was significantly improved after AlcE treatment as compared to AE treatment. Treatment with AE and AlcE decreased the lipid peroxidation and increased the antioxidant enzyme activity significantly in the sciatic nerve.

Conclusion

The results showed that Bauhinia variegata extracts may be considered as a effective option for management of diabetic neuropathy.
Literature
1.
go back to reference Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology [Internet]. 1993 [cited 2017 Nov 22];43:817–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8469345 Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology [Internet]. 1993 [cited 2017 Nov 22];43:817–24. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​8469345
2.
go back to reference Pirart J. [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author’s transl)]. Diabete Metab [Internet]. 1977 [cited 2017 Nov 22];3:245–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/598565 Pirart J. [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author’s transl)]. Diabete Metab [Internet]. 1977 [cited 2017 Nov 22];3:245–56. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​598565
4.
go back to reference Tiwari V, Kuhad A, Chopra K. Emblica officinalis Corrects Functional, Biochemical and Molecular Deficits in Experimental Diabetic Neuropathy by Targeting the Oxido-nitrosative Stress Mediated Inflammatory Cascade. Phyther Res [Internet]. 2011 [cited 2017 Nov 22];25:1527–36. Available from: http://doi.wiley.com/10.1002/ptr.3440 Tiwari V, Kuhad A, Chopra K. Emblica officinalis Corrects Functional, Biochemical and Molecular Deficits in Experimental Diabetic Neuropathy by Targeting the Oxido-nitrosative Stress Mediated Inflammatory Cascade. Phyther Res [Internet]. 2011 [cited 2017 Nov 22];25:1527–36. Available from: http://​doi.​wiley.​com/​10.​1002/​ptr.​3440
5.
11.
go back to reference EDDY NB, LEIMBACH D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther. 1953;107:385–93. EDDY NB, LEIMBACH D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther. 1953;107:385–93.
14.
go back to reference Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys Academic Press. 1959;82:70–7.CrossRef Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys Academic Press. 1959;82:70–7.CrossRef
19.
go back to reference Makadiya VS, Kulkarni YA, Apte KG. Acute and 28-day repeated dose oral toxicity of Bauhinia variegata (Caesalpiniaceae) stem bark extract. J Herbs, Spices Med Plants. Taylor and Francis Inc.; 2015;21:161–72. Makadiya VS, Kulkarni YA, Apte KG. Acute and 28-day repeated dose oral toxicity of Bauhinia variegata (Caesalpiniaceae) stem bark extract. J Herbs, Spices Med Plants. Taylor and Francis Inc.; 2015;21:161–72.
20.
go back to reference A. Shaikhomar O, S. Bahattab O. Physiological Effect of Quercetin as a Natural Flavonoid to be used as Hypoglycemic Agent in Diabetes Mellitus Type II Rats. Saudi J Biomed Res. Online) Scholars Middle East Publishers; 2021;6:10–7. A. Shaikhomar O, S. Bahattab O. Physiological Effect of Quercetin as a Natural Flavonoid to be used as Hypoglycemic Agent in Diabetes Mellitus Type II Rats. Saudi J Biomed Res. Online) Scholars Middle East Publishers; 2021;6:10–7.
21.
go back to reference Schreiber AK. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes [Internet]. Baishideng Publishing Group Inc.; 2015 [cited 2021 Jul 2];6:432. Available from: /pmc/articles/PMC4398900/ Schreiber AK. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes [Internet]. Baishideng Publishing Group Inc.; 2015 [cited 2021 Jul 2];6:432. Available from: /pmc/articles/PMC4398900/
22.
go back to reference Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? [Internet]. J. Diabetes Investig. Wiley-Blackwell; 2011 [cited 2021 Jul 2]. p. 18–32. Available from: /pmc/articles/PMC4008011/ Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? [Internet]. J. Diabetes Investig. Wiley-Blackwell; 2011 [cited 2021 Jul 2]. p. 18–32. Available from: /pmc/articles/PMC4008011/
Metadata
Title
Neuroprotective effect of Bauhinia variegata Linn. leaf extracts in streptozotocin induced diabetes in Sprague Dawley rats
Authors
Ankit P. Laddha
Mayuresh S. Garud
Yogesh A. Kulkarni
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2021
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-021-00915-y

Other articles of this Issue 2/2021

Journal of Diabetes & Metabolic Disorders 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.